ELUTIA INC. (ELUT) — Institutional Holders, Q2 2026

39 institutional investment managers reported a ELUT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $13.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ELUT in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

8

Added to

9

Trimmed

7

Sold out

4

Biggest buyers

  1. RENAISSANCE TECHNOLOGIESAdded · +119,100 sh+$116.7K
  2. VANGUARD CAPITAL MANAGEMENTAdded · +118,876 sh+$116.5K
  3. GSA CAPITAL PARTNERS LLPNew · +89,386 sh+$87.6K
  4. VANGUARD FIDUCIARYAdded · +53,101 sh+$52.0K
  5. BlackRockAdded · +45,784 sh+$44.9K

Biggest sellers

  1. AIGH Capital ManagementTrimmed · -899,606 sh-$881.3K
  2. SILVERARC CAPITAL MANAGEMENTTrimmed · -305,040 sh-$298.8K
  3. PERKINS CAPITAL MANAGEMENTTrimmed · -62,800 sh-$61.5K
  4. FNY Investment AdvisersSold out · -44,677 sh-$43.8K
  5. Arcus Capital PartnersSold out · -30,050 sh-$29.4K

ELUT 13F holders ranked 1–39 of 39

Institutional investors reporting a position in ELUTIA INC. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Nantahala Capital Management#1 · 3,184,947 sh$3.1M0.0%
AIGH Capital Management#2 · 2,695,644 sh$2.6M-25.0%
Knollwood Investment Advisory#3 · 2,556,724 sh$2.5M0.0%
SILVERARC CAPITAL MANAGEMENT#4 · 2,192,980 sh$2.1M-12.2%
VANGUARD CAPITAL MANAGEMENT#5 · 1,142,575 sh$1.1M+11.6%
PERKINS CAPITAL MANAGEMENT#6 · 694,094 sh$379.9K-8.3%
GEODE CAPITAL MANAGEMENT#7 · 285,229 sh$279.4K-2.8%
Corient Private Wealth#8 · 253,500 sh$248.3K+1.8%
RENAISSANCE TECHNOLOGIES#9 · 201,816 sh$197.7K+144.0%
VANGUARD FIDUCIARY#10 · 172,446 sh$169.0K+44.5%
BlackRock#11 · 167,857 sh$164.4K+37.5%
Birchview Capital#12 · 165,094 sh$161.7K0.0%
CITADEL ADVISORS#13 · 123,505 sh$121.0K+10.2%
Rossmore Private Capital#14 · 120,000 sh$117.6K0.0%
GSA CAPITAL PARTNERS LLP#15 · 89,386 sh$88.0KNew
XTX Topco Ltd#16 · 52,606 sh$51.5K+37.9%
JANE STREET GROUP#17 · 44,697 sh$43.8K-30.2%
NORTHERN#18 · 44,670 sh$43.8K+61.5%
Atom Investors#19 · 44,231 sh$43.3KNew
LRI Investments#20 · 25,224 sh$24.7KNew
BROWN ADVISORY#21 · 20,135 sh$19.7K0.0%
Verdence Capital Advisors#22 · 19,410 sh$19.0K0.0%
Qube Research & Technologies Ltd#23 · 17,175 sh$16.8K+0.6%
Tufton Capital Management#24 · 14,550 sh$14.0K0.0%
Indie Asset Partners#25 · 12,612 sh$12.4K0.0%
Fund Evaluation Group#26 · 12,612 sh$12.3K0.0%
STATE STREET#27 · 11,969 sh$11.7K0.0%
MERCER GLOBAL ADVISORS#28 · 11,528 sh$11.3KNew
Virtu Financial#29 · 10,936 sh$11.0KNew
Family Management#30 · 10,045 sh$9.8K0.0%
MARATHON CAPITAL MANAGEMENT#31 · 10,000 sh$9.8KNew
Vanguard Global Advisers#32 · 8,140 sh$8.0K0.0%
MORGAN STANLEY#33 · 6,971 sh$6.8K0.0%
WELLS FARGO & COMPANY#34 · 5,000 sh$4.9K0.0%
UBS Group AG#35 · 1,111 sh$1.1K-85.2%
Tower Research Capital (TRC)#36 · 767 sh$751.00-83.2%
BARCLAYS PLC#37 · 388 sh$380.00New
SBI Securities , Ltd.#38 · 55 sh$54.000.0%
Caitong International Asset Management , Ltd#39 · 1 sh$1.00New

Funds that sold out of ELUT in Q2 2026 (4)

Held ELUT at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held ELUT in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
FNY Investment Advisers44,677 sh$46.0K
Arcus Capital Partners30,050 sh$31.6K
BNP PARIBAS FINANCIAL MARKETS3 sh$3.00
ROYAL BANK OF CANADA242 sh$0.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.